Reliance Life Sciences is at the forefront of several advanced biopharmaceutical technologies, focusing on clinical research services, regenerative medicine, and specialty pharmaceuticals. The company operates as a full-service contract research organization (CRO), providing a comprehensive suite of clinical development services tailored to the needs of pharmaceutical, biotechnology, and medical device companies. Their state-of-the-art research facility in Navi Mumbai is equipped with OECD GLP certified pre-clinical labs, an 80-bed clinic, and a bioanalytical laboratory, ensuring high-quality research and compliance with global standards. The team at Reliance Life Sciences boasts extensive therapeutic experience across fourteen domains, enabling them to design and manage clinical studies effectively.

In addition to clinical research, Reliance Life Sciences is heavily involved in the development of novel cell therapies aimed at advancing regenerative medicine. The company also specializes in high-end DNA-based diagnostic testing, particularly in molecular medicine, where they emphasize delivering SMART diagnostics. Their commitment to quality is underscored by their role as one of the first private organizations approved for COVID-19 testing in India, utilizing Real Time Reverse Transcription - Polymerase Chain Reaction (RT-PCR) technology to ensure accurate and timely results. This combination of innovative research and diagnostic capabilities positions Reliance Life Sciences as a key player in the biopharmaceutical landscape.

India

Reliance Life Sciences is a medical biotechnology-led company engaged in research and development, manufacturing and marketing of differentiated medical products and services, used to treat patients primarily in intensive and critical care units in hospitals. Our core businesses are plasma proteins, biosimilars, and later generation oncology pharmaceuticals. In addition, we have initiatives in clinical research, molecular medicine, regenerative medicine, gene therapy, peptides and oligonucleotides.

Reliance Life Sciences

Company Details